View Post

Puma Biotech gets EU panel nod for breast cancer drug

In In The News by Barbara Jacoby

From: Puma Biotechnology Inc  on Friday won a key recommendation from a European Medicines Agency panel on its lead breast cancer drug, five months after the regulator recommended against approving it. Shares of Puma, which on Tuesday signaled the committee was likely to give positive opinion on the drug, neratinib, was up over 5 percent in light pre-market trading …